Published in Lancet on August 24, 2011
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother (2012) 1.62
Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant (2012) 1.44
Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol (2012) 1.39
Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol (2012) 1.36
A German outbreak of haemolytic uraemic syndrome. Lancet (2011) 0.96
Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics. Curr Opin Nephrol Hypertens (2012) 0.94
Should all adult patients with diarrhoea-associated HUS receive plasma exchange? Lancet (2012) 0.91
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther (2012) 0.86
HUS and TTP in Children. Pediatr Clin North Am (2013) 0.85
New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome. Virulence (2013) 0.84
Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant (2013) 0.83
Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed. Nephrol Dial Transplant (2012) 0.81
Attending rounds: microangiopathic hemolytic anemia with renal insufficiency. Clin J Am Soc Nephrol (2011) 0.81
Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria. BMC Microbiol (2014) 0.79
Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome. Pediatr Crit Care Med (2017) 0.78
Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature. J Med Case Rep (2016) 0.78
Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence. Infect Dis Clin North Am (2013) 0.78
Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury. Crit Care Clin (2015) 0.78
Therapy: Early plasma exchange may be beneficial in diarrhea-associated hemolytic uremic syndrome. Nat Rev Nephrol (2011) 0.75
Immunoadsorption for paediatric post-diarrhoea haemolytic-uraemic syndrome with severe neurological involvement. Clin Kidney J (2012) 0.75
Should all adult patients with diarrhoea-associated HUS receive plasma exchange? Lancet (2012) 0.75
Should all adult patients with diarrhoea-associated HUS receive plasma exchange? Lancet (2012) 0.75
Microbes without frontiers: severe haemolytic-uraemic syndrome due to E coli O104:H4. BMJ Case Rep (2012) 0.75
Diffusion-weighted imaging of the kidneys in haemolytic uraemic syndrome. Eur Radiol (2017) 0.75
Guidelines for the management and investigation of hemolytic uremic syndrome. Clin Exp Nephrol (2014) 0.75
Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet (2007) 3.00
Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res (2007) 2.47
Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab (2010) 2.11
Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring) (2007) 1.67
Epidemiology of Massive Transfusion: A Binational Study From Sweden and Denmark. Crit Care Med (2016) 1.47
Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus. Biochem Biophys Res Commun (2004) 1.47
Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure. Circulation (2004) 1.46
High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome. Metabolism (2007) 1.45
Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution. Perit Dial Int (2003) 1.39
Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes (2008) 1.16
Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats. Hypertension (2008) 1.16
Survival after blood transfusion. Transfusion (2008) 1.14
Transient receptor potential canonical type 3 channels--their evolving role in hypertension and its related complications. J Cardiovasc Pharmacol (2013) 1.10
Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol (2006) 1.10
Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase. Hypertension (2004) 1.08
Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Biochem Biophys Res Commun (2007) 1.06
High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes. Diabetes (2010) 1.01
Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. Hypertension (2010) 1.00
Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion (2007) 0.98
Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst (2008) 0.96
Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovasc Res (2011) 0.95
Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis (2008) 0.94
Transient receptor potential channels in essential hypertension. J Hypertens (2006) 0.93
Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels. J Cell Mol Med (2010) 0.92
Blood transfusion exposure in Denmark and Sweden. Transfusion (2009) 0.92
The role of transient receptor potential channels in metabolic syndrome. Hypertens Res (2008) 0.92
Increased transient receptor potential channel TRPC3 expression in spontaneously hypertensive rats. Am J Hypertens (2005) 0.91
Increased TRPC3 expression in vascular endothelium of patients with malignant hypertension. Mod Pathol (2009) 0.91
Identification and quantification of diadenosine polyphosphate concentrations in human plasma. Arterioscler Thromb Vasc Biol (2003) 0.90
High glucose enhances transient receptor potential channel canonical type 6-dependent calcium influx in human platelets via phosphatidylinositol 3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol (2008) 0.89
Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus. Ther Drug Monit (2015) 0.89
Endogenous glycosides in critically ill patients. Crit Care Med (2003) 0.88
Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uraemia? Nephrol Dial Transplant (2003) 0.87
Mean platelet volume and coronary heart disease in hemodialysis patients. Kidney Blood Press Res (2002) 0.87
Sleep-related breathing disorders impair quality of life in haemodialysis recipients. Nephrol Dial Transplant (2002) 0.87
Increased migration of monocytes in essential hypertension is associated with increased transient receptor potential channel canonical type 3 channels. PLoS One (2012) 0.87
Endothelial dysfunction in cold-induced hypertensive rats. Am J Hypertens (2002) 0.86
Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat. Nephrol Dial Transplant (2003) 0.85
Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J Lab Clin Med (2006) 0.85
Increased store-operated and 1-oleoyl-2-acetyl-sn-glycerol-induced calcium influx in monocytes is mediated by transient receptor potential canonical channels in human essential hypertension. J Hypertens (2007) 0.85
Importance of hyperglycemia on the primary function of allogeneic islet transplants. Transplantation (2003) 0.85
Monocytes from spontaneously hypertensive rats show increased store-operated and second messenger-operated calcium influx mediated by transient receptor potential canonical Type 3 channels. Am J Hypertens (2007) 0.85
Transient receptor potential canonical type 3 channels and blood pressure in humans. J Hypertens (2009) 0.84
Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction. J Cardiovasc Pharmacol (2002) 0.84
Role of leptin in reverse epidemiology in chronic kidney disease. Semin Dial (2007) 0.84
Association of transient receptor potential canonical type 3 (TRPC3) channel transcripts with proinflammatory cytokines. Arch Biochem Biophys (2007) 0.84
Pulsatile atheroprone shear stress affects the expression of transient receptor potential channels in human endothelial cells. Hypertension (2012) 0.83
Effects of dinucleoside polyphosphates on regulation of coronary vascular tone. Eur J Pharmacol (2002) 0.83
Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters. Biochem Biophys Res Commun (2010) 0.83
VEGF regulates TRPC6 channels in podocytes. Nephrol Dial Transplant (2011) 0.83
Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients. Kidney Blood Press Res (2013) 0.83
Noninvasive pulse wave analysis for the determination of central artery stiffness. Microvasc Res (2008) 0.83
Superoxide dismutase type 1 in monocytes of chronic kidney disease patients. Amino Acids (2010) 0.82
Impaired vascular reactivity in patients with chronic kidney disease. Am J Nephrol (2007) 0.81
Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens (2002) 0.81
Effects of glucocorticoids on generation of reactive oxygen species in platelets. Steroids (2002) 0.81
Low density lipoproteins inhibit the Na+/H+ antiport in human platelets via activation of p38MAP kinase. Biochem Biophys Res Commun (2005) 0.81
Immunosuppression in xenotransplantation with Wf10. Pharmacol Toxicol (2002) 0.81
A possible new diagnostic biomarker in early diagnosis of Alzheimer's disease. Curr Alzheimer Res (2009) 0.81
Preventing nephropathy induced by contrast medium. N Engl J Med (2006) 0.80
Graft versus host disease with glomerular infiltration of CD8+/perforin+ cytotoxic T lymphocytes causes nephrotic syndrome. Transplantation (2011) 0.80
Sustained increase of extracellular calcium concentration causes arterial vasoconstriction in humans. J Hypertens (2005) 0.80
GATA4-mediated cardiac hypertrophy induced by d-myo-inositol 1,4,5-tris-phosphate. Biochem Biophys Res Commun (2005) 0.80
Positive predictive value of serological diagnostic measures in celiac disease. Clin Chem Lab Med (2010) 0.80
Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy. Nephron Clin Pract (2007) 0.80
Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23. J Clin Endocrinol Metab (2014) 0.79
Low expression of thiosulfate sulfurtransferase (rhodanese) predicts mortality in hemodialysis patients. Clin Biochem (2009) 0.79
Tissue expression of TRPC3 and TRPC6 in hypertensive Munich Wistar Frömter rats showing proteinuria. Am J Nephrol (2009) 0.79
A biomarker for severity of Alzheimer's disease: 1H-NMR resonances in cerebrospinal fluid correlate with performance in mini-mental-state-exam. Biomarkers (2012) 0.79
Increased transient receptor potential vanilloid type 1 (TRPV1) channel expression in hypertrophic heart. Biochem Biophys Res Commun (2010) 0.79
Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5. Ther Apher Dial (2009) 0.79
The renal arterial resistive index and stage of chronic kidney disease in patients with renal allograft. PLoS One (2012) 0.79
Effect of sodium on blood pressure, cardiac hypertrophy, and angiotensin receptor expression in rats. Am J Hypertens (2004) 0.78
The proteoglycan syndecan 4 regulates transient receptor potential canonical 6 channels via RhoA/Rho-associated protein kinase signaling. Arterioscler Thromb Vasc Biol (2011) 0.78
Continuous reduction of plasma paraoxonase activity with increasing dialysis vintage in hemodialysis patients. Ther Apher Dial (2010) 0.78
Clinical implications of converting stable haemodialysis patients from subcutaneous to intravenous administration of darbepoetin alfa. Nephrol Dial Transplant (2006) 0.78
Cutaneous Mycobacterium abscessus infection after kidney transplantation. Nephrol Dial Transplant (2005) 0.78
Mortality risk in hemodialysis patients with increased arterial stiffness is reduced by attainment of classical clinical performance measures. Am J Nephrol (2009) 0.77
Does N-acetylcysteine modulate post-translational modifications of transthyretin in hemodialysis patients? Antioxid Redox Signal (2013) 0.77
Mass spectrometry-assisted protease substrate screening. Anal Chem (2007) 0.77
Effect of renal replacement therapy on retinol-binding protein 4 isoforms. Clin Chim Acta (2008) 0.77
Noninvasive cardiac output determination using applanation tonometry-derived radial artery pulse contour analysis in critically ill patients. Anesth Analg (2008) 0.77
Differentially expressed genes in hypertensive rats developing cerebral ischemia. Life Sci (2004) 0.77
Nasal continuous positive airway pressure: influence on digital volume pulse in obstructive sleep apnoea patients. Eur Respir J (2011) 0.77
Cesarean section: is pretransfusion testing for red cell alloantibodies necessary? Acta Obstet Gynecol Scand (2005) 0.76
Erythropoietin increases expression and function of transient receptor potential canonical 5 channels. Hypertension (2011) 0.76
Decreased expression of transient receptor potential channels in cerebral vascular tissue from patients after hypertensive intracerebral hemorrhage. Clin Exp Hypertens (2011) 0.76
N-acetylcysteine improves arterial vascular reactivity in patients with chronic kidney disease. Nephron Clin Pract (2009) 0.76
Association of systemic collagen type IV formation with survival among patients undergoing hemodialysis. PLoS One (2013) 0.76
Identification and characterization of adenosine 5'-tetraphosphate in human myocardial tissue. J Biol Chem (2003) 0.75
Sleep is more than a break from life. Eur Heart J (2006) 0.75
Identification of a potent endothelium-derived angiogenic factor. PLoS One (2013) 0.75
Calcium-dependent expression of transient receptor potential canonical type 3 channels in patients with chronic kidney disease. Arch Biochem Biophys (2011) 0.75
Insulin Increases Expression of TRPC6 Channels in Podocytes by a Calcineurin-Dependent Pathway. Cell Physiol Biochem (2016) 0.75
The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model. APMIS (2003) 0.75
Green urine following exposure to flupirtine. Am J Kidney Dis (2010) 0.75
Acute megakaryoblastic leukemia AML FAB-M7 in a patient 15 years after kidney transplantation. Ann Hematol (2010) 0.75
Does prophylactic haemodialysis protect kidney function after angiography? Nephrol Dial Transplant (2008) 0.75
Extensive leukemic kidney infiltration with membranoproliferative glomerulonephritis in a patient with B-cell chronic lymphocytic leukemia. Ann Hematol (2007) 0.75
[Hyponatremia]. Med Klin (Munich) (2009) 0.75